EMA to review linerixibat for itch in primary biliary cholangitis
The European Medicines Agency (EMA) will review an application for linerixibat, an experimental oral therapy for intense itching associated with primary biliary cholangitis (PBC).
Lila Levinson, PhD, Science Writer—
Articles by Lila Levinson, PhD
Mononucleosis linked to higher risk of developing PSC: Study
People who have experienced mononucleosis, or mono, which is caused by an infection of the Epstein-Barr virus (EBV), are 12 times more likely to develop…
New MYO5B gene mutation detected in man with PFIC type 10
A combination of two mutations in the MYO5B gene, including one that has not been previously reported, was the likely cause of a mild form…
Trial of golexanolone for PBC cognitive symptoms to resume
A Phase 1b/2a clinical trial of golexanolone, Umecrine Cognition’s candidate therapy for cognitive symptoms and fatigue related to primary biliary cholangitis (PBC), will resume…
